Robust reduction of HBsAg and HDV RNA levels with low risk for ALT elevations in JNJ-73763989 treated patients with chronic hepatitis D (CHD) and baseline HBsAg levels below 10, 000 IU/ml: part 2 of the REEF-D study

---

Wedemeyer H., Lampertico P., Gane E. J., Agarwal K., TABAK Ö. F., AKARCA U. S., ...More

European-Association-for-the-Study-of-the-Liver Congress (EASL), Milan, Italy, 5 - 08 June 2024, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• City: Milan
• Country: Italy
• Istanbul University-Cerrahpasa Affiliated: Yes